Clinical Trial Update: FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic Hyperplasia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing FLOMAX (tamsulosin) and HYTRIN (terazosin) in men with benign prostatic hyperplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Flomax (tamsulosin hydrochloride)
• HYTRIN (terazosin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Prostatic Hyperplasia | Phase 4 | Status: COMPLETED